N@N

Calvin Sternick Initiated (THC) at Buy and Held Target at $72 on, Apr 19th, 2023

Calvin Sternick of JP Morgan, Initiated "Tenet Healthcare Corporation" (THC) at Buy and Held Target at $72 on, Apr 19th, 2023.

Calvin has made no other calls on THC in the last 4 months.

There are 8 other peers that have a rating on THC. Out of the 8 peers that are also analyzing THC, 1 agrees with Calvin's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $64 on, Wednesday, February 22nd, 2023

These are the ratings of the 7 analyists that currently disagree with Calvin

---

• Stephen Baxter of "Wells Fargo" Maintained at Buy with Increased Target to $68 on, Friday, February 17th, 2023
• Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $78 on, Friday, February 17th, 2023
• Steve Valiquette of "Barclays" Maintained at Buy with Increased Target to $70 on, Tuesday, February 14th, 2023
• Andrew Mok of "UBS" Maintained at Strong Buy with Increased Target to $78 on, Tuesday, February 14th, 2023
• Ben Hendrix of "RBC Capital" Maintained at Buy with Increased Target to $73 on, Friday, February 10th, 2023
• David Macdonald of "Truist Securities" Maintained at Strong Buy with Increased Target to $66 on, Friday, February 10th, 2023
• Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $65 on, Friday, February 10th, 2023

Contributing Sources

---